For help on how to get the results you want, see our search tips.
308 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Withdrawn applications Remove Withdrawn applications filter
Categories
Human Remove Human filter
-
List item
Withdrawn application: Iclusig (updated)
ponatinib, date of withdrawal: 11/08/2023, Post-authorisation, Last updated: 30/11/2023 -
List item
Withdrawn application: Bylvay (updated)
odevixibat, date of withdrawal: 22/10/2023, Post-authorisation, Last updated: 23/11/2023 -
List item
Withdrawn application: Gefzuris (updated)
gefapixant, date of withdrawal: 14/07/2023, Initial authorisation, Last updated: 08/11/2023 -
List item
Withdrawn application: RoActemra (updated)
tocilizumab, date of withdrawal: 13/09/2023, Post-authorisation, Last updated: 07/11/2023 -
List item
Withdrawn application: Lutholaz (updated)
date of withdrawal: 19/07/2023, Initial authorisation, Last updated: 07/11/2023 -
List item
Withdrawn application: Vivjoa
Oteseconazole, date of withdrawal: 24/08/2023, Initial authorisation, Last updated: 23/10/2023 -
List item
Withdrawn application: Gazyvaro
obinutuzumab, date of withdrawal: 04/07/2023, Post-authorisation, Last updated: 04/10/2023 -
List item
Withdrawn application: Zefylti
filgrastim, date of withdrawal: 08/06/2023, Initial authorisation, Last updated: 30/08/2023 -
List item
Withdrawn application: Lagevrio
molnupiravir, date of withdrawal: 21/06/2023, Initial authorisation, Last updated: 09/08/2023 -
List item
Withdrawn application: Lumevoq
lenadogene nolparvovec, date of withdrawal: 20/04/2023, Initial authorisation, Last updated: 08/08/2023 -
List item
Withdrawn application: Susvimo
ranibizumab, date of withdrawal: 02/05/2023, Initial authorisation, Last updated: 18/07/2023 -
List item
Withdrawn application: Feraheme
ferumoxytol, date of withdrawal: 09/03/2023, Initial authorisation, Last updated: 11/07/2023 -
List item
Withdrawn application: Asimtufii
aripiprazole, date of withdrawal: 02/05/2023, Initial authorisation, Last updated: 07/07/2023 -
List item
Withdrawn application: Tidhesco
ivosidenib, date of withdrawal: 27/03/2023, Initial authorisation, Last updated: 21/06/2023 -
List item
Withdrawn application: Buvidal
buprenorphine, date of withdrawal: 13/02/2023, Post-authorisation, Last updated: 14/06/2023 -
List item
Withdrawn application: Raltegravir Viatris
raltegravir potassium, date of withdrawal: 22/02/2023, Initial authorisation, Last updated: 21/04/2023 -
List item
Withdrawn application: Ilaris
canakinumab, date of withdrawal: 26/10/2022, Post-authorisation, Last updated: 23/02/2023 -
List item
Withdrawn application: Aliqopa
copanlisib, date of withdrawal: 20/12/2021, Initial authorisation, Last updated: 10/02/2023 -
List item
Withdrawn application: Miplyffa
arimoclomol, date of withdrawal: 22/03/2022, Initial authorisation, Last updated: 08/02/2023 -
List item
Withdrawn application: Imbarkyd
bardoxolone methyl, date of withdrawal: 09/11/2022, Initial authorisation, Last updated: 07/02/2023 -
List item
Withdrawn application: Gavreto
pralsetinib, date of withdrawal: 03/11/2022, Post-authorisation, Last updated: 02/02/2023 -
List item
Withdrawn application: Olumiant
baricitinib, date of withdrawal: 07/12/2022, Post-authorisation, Last updated: 02/02/2023 -
List item
Withdrawn application: Febseltiq
infigratinib, date of withdrawal: 11/10/2022, Initial authorisation, Last updated: 30/01/2023 -
List item
Withdrawn application: Hervelous
trastuzumab, date of withdrawal: 14/09/2022, Initial authorisation, Last updated: 13/12/2022 -
List item
Withdrawn application: Tuznue
trastuzumab, date of withdrawal: 14/09/2022, Initial authorisation, Last updated: 13/12/2022